Atlanta Consulting Group Advisors’s Eli Lilly LLY Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$663K	Sell	721 -86	-11%	-$87.2K	0.14%	80
2025 Q4	$867K	Buy	807 +69	+9%	+$66K	0.2%	62
2025 Q3	$563K	Buy	738 +1	+0.1%	+$744	0.14%	77
2025 Q2	$575K	Sell	737 -5	-0.7%	-$3.88K	0.16%	68
2025 Q1	$613K	Sell	742 -9	-1%	-$7.49K	0.18%	65
2024 Q4	$580K	Sell	751 -26	-3%	-$21.5K	0.21%	68
2024 Q3	$688K	Buy	777 +242	+45%	+$218K	0.17%	106
2024 Q2	$484K	Buy	535 +66	+14%	+$52.8K	0.1%	73
2024 Q1	$365K	Buy	+469	New	+$334K	0.13%	88

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Atlanta Consulting Group Advisors's LLY Position: Q1 2026 in Review

Atlanta Consulting Group Advisors reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $87.2K and leaving 721 shares worth $663K. The position accounts for 0.14% of the portfolio, ranked #80.

Atlanta Consulting Group Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $867K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Atlanta Consulting Group Advisors held 721 shares of Eli Lilly worth $663K as of Q1 2026.
Atlanta Consulting Group Advisors sold 86 Eli Lilly shares in Q1 2026, an estimated $87.2K.
Eli Lilly made up 0.14% of Atlanta Consulting Group Advisors's portfolio in Q1 2026, its #80 holding.
Atlanta Consulting Group Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Atlanta Consulting Group Advisors's Eli Lilly position peaked at $867K in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.